November 2, 2023

Rare missense variants in protein intrinsically disordered regions: impact on condensates and common diseases

Poster presented at the American Society of Human Genetics Annual Meeting 2023

> Download the PDF file

Media Contact

Investor Contact

Scott Peterson, Ph.D.
SVP, Corporate Development and Investor Relations
Dewpoint Therapeutics
Dewpoint Therapeutics
451 D Street, Suite 104
Boston, MA 02210
© 2019-2023 - Dewpoint Therapeutics

Design: SALIENCE Communication / Publiepress
Scientific animation: Visual Science